Genedx Holdings Corp (WGS) Stock Price, Quote & News

Company Profile

GeneDx Holdings Corp., a genomics company, provides genetic testing services. It primarily offers pediatric and rare disease diagnostics with a focus on whole exome and genome sequencing, as well as data and information services. The company also develops an AI-based platform for NGS analysis, interpretation, and clinical reporting for rare disease, hereditary risk, and cancer testing. The company is headquartered in Stamford, Connecticut.

Industry: Diagnostics & Research

Sector: Healthcare

Phone: 888 729 1206

Fax: 201 421 2010

Website: www.genedx.com

Address:

North Tower, 6th Floor 333 Ludlow Street, Stamford, United States

CarverX Jul. 15 at 4:23 PM

$WGS SA article on WGS. https://seekingalpha.com/article/4801227-genedx-strong-testing-volume-an-invaluable-genomic-database

1 · Reply

CarverX Jul. 15 at 3:54 PM

$WGS Strong support at 80 fibonacci🚀🚀🚀

0 · Reply

Energy2024 Jul. 15 at 11:16 AM

$WGS Future ‼️‼️ 1000,-€‼️‼️

0 · Reply

tymtested Jul. 13 at 10:20 PM

$WGS I’d buy a million shares if I could!

1 · Reply

Energy2024 Jul. 11 at 8:22 PM

$WGS 1000,-€‼️🚀🚀

0 · Reply

StockHunter75 Jul. 11 at 3:24 PM

$WGS she's bottomed out good time to load up.

0 · Reply

StockHunter75 Jul. 11 at 1:42 PM

$WGS added

0 · Reply

StockbobSquaregainz Jul. 10 at 7:37 PM

$WGS 🎯

0 · Reply

StockbobSquaregainz Jul. 10 at 5:52 PM

$WGS no love

0 · Reply

spongebob_squaretrades Jul. 10 at 1:51 PM

$WGS ER 7/29. Confirmed. https://ir.genedx.com/news-releases/news-release-details/genedx-report-second-quarter-2025-financial-results-tuesday-july

0 · Reply

GeneDx: Strong Testing Volume And An Invaluable Genomic Database

Jul 10, 2025, 8:30 AM EDT - 5 days ago

GeneDx to Report Second Quarter 2025 Financial Results on Tuesday, July 29, 2025

Jun 25, 2025, 8:30 AM EDT - 20 days ago

GeneDx Announces Publication of SeqFirst Study Demonstrating Need for First Tier Rapid Genomic Testing for Non-Critical Care Pediatric Inpatients in The Journal of Pediatrics

Jun 23, 2025, 3:17 PM EDT - 22 days ago

GeneDx Announces American Academy of Pediatrics Recommends Exome and Genome Sequencing as First-Tier Tests for Children with Global Developmental Delay or Intellectual Disability

Jun 16, 2025, 11:41 AM EDT - 4 weeks ago

WGS Investors Have Opportunity to Join GeneDx Holdings Corp. Fraud Investigation with the Schall Law Firm

May 22, 2025, 4:05 PM EDT - 7 weeks ago

GeneDx to Participate in Upcoming Investor Conferences

May 22, 2025, 8:00 AM EDT - 7 weeks ago

GeneDx Publishes Pioneering Vision for Applying AI to Genomics to Improve and Expedite Diagnosis of Genetic Disease at Scale

May 20, 2025, 5:21 AM EDT - 2 months ago

GeneDx: Strong Fundamentals Intact As Market Misreads Test Volume Dip

May 14, 2025, 5:35 AM EDT - 2 months ago

GeneDx: Time To Buy The Dip

May 7, 2025, 8:30 AM EDT - 2 months ago

GeneDx Announces Completion of Fabric Genomics Acquisition

Apr 30, 2025, 1:15 PM EDT - 2 months ago

GeneDx Holdings Corp. (WGS) Q1 2025 Earnings Call Transcript

Apr 30, 2025, 6:30 AM EDT - 2 months ago

GeneDx Reports First Quarter 2025 Financial Results and Business Highlights

Apr 28, 2025, 11:13 AM EDT - 2 months ago

GeneDx: Strengthening Leadership In Genomic Diagnostics

Apr 16, 2025, 6:00 AM EDT - 3 months ago

GeneDx to Acquire Fabric Genomics, Enabling Decentralized, AI-Powered Testing at Global Scale

Apr 8, 2025, 8:05 AM EDT - 3 months ago

GeneDx to Report First Quarter 2025 Financial Results on Wednesday, April 30, 2025

Apr 3, 2025, 8:00 AM EDT - 3 months ago

GeneDx Expands Commercial Footprint for Exome and Genome Testing with Inborn Errors of Immunity as a New Indication

Mar 20, 2025, 4:05 PM EDT - 4 months ago

GeneDx Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Mar 18, 2025, 7:05 AM EDT - 4 months ago

Fast Company Recognizes GeneDx as One of the World's Most Innovative Companies

Mar 13, 2025, 8:30 AM EDT - 4 months ago

GeneDx to Showcase Key Research and Innovation at the 2025 American College of Medical Genetics (ACMG) Annual Meeting

Mar 13, 2025, 8:30 AM EDT - 4 months ago

GeneDx Enhances the Power of its Interpretation Platform with Artificial Intelligence (AI) Powered Gene Ranker to Enable Faster and More Efficient Clinical Analysis

Mar 12, 2025, 1:13 PM EDT - 4 months ago

GeneDx Holdings: There Is Upside Potential, But Price Tag Is Rich

Mar 4, 2025, 8:30 AM EST - 4 months ago

GeneDx Expands Commercial Footprint for Exome and Genome Testing with Cerebral Palsy as a New Indication

Feb 25, 2025, 10:00 AM EST - 5 months ago

Bronstein, Gewirtz & Grossman, LLC Is Investigating GeneDx Holdings Corp. (WGS) And Encourages Shareholders to Connect

Feb 24, 2025, 11:00 AM EST - 5 months ago

Landmark Seqfirst-neo Study Showcases the Significant Impact of Genomic Testing in the NICU, Revealing Gaps in Current Protocols

Feb 24, 2025, 10:00 AM EST - 5 months ago

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against GeneDx Holdings Corp. (WGS) And Encourages Shareholders to Reach Out

Feb 23, 2025, 10:00 AM EST - 5 months ago

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against GeneDx Holdings Corp. (WGS) and Encourages Shareholders to Learn More About the Investigation

Feb 21, 2025, 10:00 AM EST - 5 months ago

GeneDx Holdings Corp. (WGS) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation

Feb 20, 2025, 10:00 AM EST - 5 months ago

GeneDx Holdings Corp. (WGS) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation

Feb 19, 2025, 10:00 AM EST - 5 months ago

Bronstein, Gewirtz & Grossman, LLC Is Investigating GeneDx Holdings Corp. (WGS) And Encourages Investors to Connect

Feb 19, 2025, 9:29 AM EST - 5 months ago

Reviewing GeneDx Holdings: Exome Testing And EPIC Aura Integration Make It A GARP 'Buy'

Feb 18, 2025, 3:54 PM EST - 5 months ago

GeneDx CEO on pediatric genetic testing, future of genome sequencing and share surge

Feb 18, 2025, 11:02 AM EST - 5 months ago

GeneDx Holdings Corp. (WGS) Q4 2024 Earnings Call Transcript

Feb 18, 2025, 10:00 AM EST - 5 months ago

Bronstein, Gewirtz & Grossman, LLC Encourages GeneDx Holdings Corp. (WGS) Stockholders to Inquire about Securities Investigation

Feb 18, 2025, 6:00 AM EST - 5 months ago

GeneDx Reports Fourth Quarter and Full Year 2024 Financial Results and Issues Guidance for Full Year 2025

Feb 17, 2025, 10:00 AM EST - 5 months ago

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against GeneDx Holdings Corp. (WGS) and Encourages Investors to Learn More About the Investigation

Feb 14, 2025, 10:00 AM EST - 5 months ago

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against GeneDx Holdings Corp. (WGS) And Encourages Stockholders to Reach Out

Feb 13, 2025, 10:00 AM EST - 5 months ago

Bronstein, Gewirtz & Grossman, LLC Is Investigating GeneDx Holdings Corp. (WGS) And Encourages Stockholders to Connect

Feb 13, 2025, 8:30 AM EST - 5 months ago

GeneDx Announces ultraRapid Whole Genome Sequencing, Delivering Actionable Results in as soon as 48 Hours to Inform Care for Critically Ill NICU and PICU Patients

Feb 12, 2025, 4:05 PM EST - 5 months ago

GeneDx to Participate in 45th Annual TD Cowen Health Care Conference

Feb 12, 2025, 10:00 AM EST - 5 months ago

GeneDx Holdings Corp. (WGS) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation

Feb 11, 2025, 10:00 AM EST - 5 months ago

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against GeneDx Holdings Corp. (WGS) and Encourages Stockholders to Learn More About the Investigation

CarverX Jul. 15 at 4:23 PM

$WGS SA article on WGS. https://seekingalpha.com/article/4801227-genedx-strong-testing-volume-an-invaluable-genomic-database

1 · Reply

CarverX Jul. 15 at 3:54 PM

$WGS Strong support at 80 fibonacci🚀🚀🚀

0 · Reply

Energy2024 Jul. 15 at 11:16 AM

$WGS Future ‼️‼️ 1000,-€‼️‼️

0 · Reply

tymtested Jul. 13 at 10:20 PM

$WGS I’d buy a million shares if I could!

1 · Reply

Energy2024 Jul. 11 at 8:22 PM

$WGS 1000,-€‼️🚀🚀

0 · Reply

StockHunter75 Jul. 11 at 3:24 PM

$WGS she's bottomed out good time to load up.

0 · Reply

StockHunter75 Jul. 11 at 1:42 PM

$WGS added

0 · Reply

StockbobSquaregainz Jul. 10 at 7:37 PM

$WGS 🎯

0 · Reply

StockbobSquaregainz Jul. 10 at 5:52 PM

$WGS no love

0 · Reply

spongebob_squaretrades Jul. 10 at 1:51 PM

$WGS ER 7/29. Confirmed. https://ir.genedx.com/news-releases/news-release-details/genedx-report-second-quarter-2025-financial-results-tuesday-july

0 · Reply

Energy2024 Jul. 10 at 10:07 AM

$WGS 1000,- Coming soon quickly‼️‼️

0 · Reply

vjtweet Jul. 10 at 3:48 AM

$WGS a couple of days tight range is fantastic. Has a starter position.

0 · Reply

CarverX Jul. 9 at 6:10 PM

$WGS Nice support at 87 fib retrace (50%) now looking to try to break through resistance at 94 (38.2%) 🚀🚀🚀

0 · Reply

CarverX Jul. 9 at 4:52 PM

$TGTX $WGS Making good runs today 🚀🚀🚀

0 · Reply

CarverX Jul. 9 at 4:49 PM

$WGS 🚀🚀🚀 Genetic med is wave of future and just getting started. Let’s goooooooooo!! Chan Zuckerberg Initiative, Innovative Genomics Institute Announce New Center for Pediatric CRISPR Cures The Center will advance on-demand gene-editing cures for children with severe genetic diseases. Today, the Chan Zuckerberg Initiative and the Innovative Genomics Institute (IGI) announced the funding of the Center for Pediatric CRISPR Cures (Center)

0 · Reply

StockbobSquaregainz Jul. 9 at 3:38 PM

$WGS saw old account statements earlier from 2021 when I originally owned this (or CMLF/Sema4 warrants) …oh boy what a time. Nibbled on some warrants in the meantime for old times sake… let’s see.

1 · Reply

CarverX Jul. 9 at 3:34 PM

$WGS 90s are back🚀🚀🚀

0 · Reply

CarverX Jul. 9 at 3:27 PM

$WGS As I said yesterday as well as months ago 🚀🚀🚀

0 · Reply

CarverX Jul. 9 at 3:24 PM

$WGS On July 9, 2025, GeneDx Holdings (WGS, Financial), a prominent company in the genetic diagnostics sector, received a significant boost as Piper Sandler initiated coverage with an "Overweight" rating. This positive outlook from the financial analysts at Piper Sandler comes as an encouraging development for GeneDx Holdings. The move to initiate coverage with an "Overweight" rating was announced by David Westenberg, a well-regarded analyst at Piper Sandler. In addition to the positive rating, a price target of USD 110.00 was set for GeneDx Holdings (WGS, Financial). This target underscores the analysts' confidence in the company's future performance in the marketplace.

0 · Reply

MaverikIT Jul. 9 at 3:14 PM

@WAJeff $WGS +5.72 that drop was da gift

0 · Reply

MaverikIT Jul. 9 at 2:47 PM

@Monkey_Banana_Genius $WGS - changing perception$ yet ?

0 · Reply

JarvisFlow Jul. 9 at 12:30 PM

Piper Sandler has adjusted their stance on GeneDx Holdings ( $WGS ), setting the rating to Overweight with a target price of 110.

0 · Reply

Market Cap	2.36B
Revenue (ttm)	305.45M
Net Income (ttm)	-52.29M
EPS (ttm)	N/A
PE Ratio	95.51
Forward PE	87.79
Profit Margin	-17.12%
Debt to Equity Ratio	0.20

Volume	496,609
Avg Vol	1,092,814
Day's Range	N/A - N/A
Shares Out	28.53M
Stochastic %K	2%
Beta	2.01
Analysts	Strong Sell
Price Target	$101.53